Department of Conservative Dentistry, College of Dentistry, Dankook University, Cheonan, Korea.
Copyright © 2020. The Korean Academy of Conservative Dentistry
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Material base | Products | Manufacturer | Composition |
---|---|---|---|
ZOE | Roth's 801 [M] | Roth International, Miami, FL, USA | Powder: zinc oxide, staybelite resin, bismuth sub-carbonate, barium sulfate, sodium borate; Liquid: eugenol |
Pulp Canal sealer [M] | Kerr, Orange, CA, USA | Powder: zinc oxide 30%–60%, 5,5′-diisopropyl-2,2′-dimethylbiphenyl-4,4′-diyl dihypoiodite 0.1%–5%; Liquid: eugenol 60%–90%, Canada balsam 10%–30% | |
Tubli Seal [M] | Kerr, Orange, CA, USA | Base: zinc oxide 60%–100%, white mineral oil (petroleum) 10%–30%; Accelerator: eugenol 30%–60%, 5,5′-diisopropyl-2,2′-dimethylbiphenyl-4,4′-diyl dihypoiodite 5%–10% | |
Endo N2 [M] | Ghimas, Casalecchio di Reno, Italy | Powder: zinc oxide 65.68%, nitrate bismuth 15.17%, carbonate bismuth 10.1%, paraformaldehyde 4%, titanium dioxide 4.76%, red ferric oxide 0.1%, zinc stearate 0.075%, dehydrate zinc acetate 0.075%, yellow ferric oxide 0.04%; Liquid: eugenol 77%, peanut oil 20%, rose oil 1.8%, lavender oil 1.2% | |
CH | Sealapex root canal sealer [M] | Kerr, Orange, CA, USA | Base: N-ethyl-o (or p)-toluenesulfonamide 30%–60%, calcium oxide 30%–60%, zinc oxide 1%–5%, zinc distearate 1%–5%; Catalyst: methyl salicylate 10%–30%, 2,2 dimethylpropane-1,3-diol 1%–5%, isobutyl salicylate 1%–5% |
Apexit Plus [M] | Ivoclar Vivadent AG, Schaan, Liechtenstein | Base: calcium hydroxide/calcium oxide 36.9%, hydrated colophonium 54%, fillers and other auxiliary materials 9.1%; Activator: disalicylate 47.6%, bismuth hydroxide/bismuth carbonate 36.4%, fillers and other auxiliary materials 16% | |
ER | AH 26 [M] | Dentsply DeTrey, Konstanz, Germany | Powder: methenamine 25%–50%, titanium dioxide 2.5%–10%, silver 2.5%; Liquid: bisphenol A/epichlorohydrin resin 50%–100% |
AH Plus [M] | Dentsply DeTrey, Konstanz, Germany | Paste A: bisphenol A diglycidylether 25%–50%, bis-[4-(-2,3-epoxypropoxy) phenyl]-methane 2.5%–10%; Paste B: N,N′-dibenzyl-5-oxanonandiamin-1,9 10%–25%, amantadine 2.5%–10% | |
Acroseal [M] | Septodont, Saint-Maur-des-Fossés, France | Base: resin acids, hydrogenated 25%–50%, TCD-diamine 10%–25%; Catalyst: bisphenol-A-(epichlorohydrin) epoxy resin 50%–100%, calcium dihydroxide 10%–25% | |
Easyseal [M] | Komet Brasseler, GmbH Co., Lemgo, Germany | Paste 1: 4-[-2-(4-hydroxyphenyl) propan-2-yl] phenol-epichlorohydrine resin, alkylglycidyl ether, barium sulfate, tricalcium phosphate, diphenylolpropane-diglycidyl ether; Paste 2: polyalkoxyalkylamine-copolymer, 5-amino-1,3,3-trimethylcyclohexanmethylamine, aqua, barium sulfate, tricalcium phosphate, nanodispers silicone dioxide, polyhexamethylene biguanides-hydrochloride | |
Theramseal [M] | Dentsply Meillefer, Konstanz, Germany | Paste A: epoxy resin, calcium tungstate, zirconium oxide, aerosol, iron oxide; Paste B: Adamantane amine, N,N′-dibenzyl-5-oxanonandiamin-1,9, TCD-diamine, calcium tungstate, zirconium oxide aerosol, silicone oil | |
Topseal [M] | Dentsply Meillefer, Ballaigues, Switzerland | Paste A: epoxy resin, calcium tungstate, zirconium oxide, aerosol, iron oxide; Paste B: adamantane amine, N,N′-dibenzyl-5-oxanonandiamin-1,9, TCD-diamine, calcium tungstate, zirconium oxide aerosol, silicone oil | |
MR | Endorez [M] | Ultradent Product Inc., South Jordan, UT, USA | Base: diurethane dimethacrylate > 10 and ≤ 25%, triethylene glycol dimethacrylate > 10 and ≤ 25%, organophosphine oxide ≤ 2.5%, benzoyl peroxide ≤ 2.5%; Catalyst: diurethane dimethacrylate > 25 and ≤ 50%, triethylene glycol dimethacrylate > 10 and ≤ 25% |
RealSeal (Eldeniz et al. [59]) | SybronEndo, Orange, CA, USA | PEGDMA, EBPADMA, EDMA, BisGMA, silane-treated barium borosilicate glasses, barium sulphate, silica, calcium hydroxide, bismuth oxychloride with amines, peroxide, photoinitiator, stabilizers, pigment | |
RealSeal SE [59] | SybronEndo, Orange, CA, USA | EBPADMA, HEMA, BisGMA, acidic methacrylate resins, barium borosilicate glasses, silica, hydroxyapatite, Ca-Al-F-silicate, bismuth oxychloride with amines, peroxide, photoinitiator, stabilizers, pigment, aluminium oxide | |
Hybrid Root Seal [59] | Sun Medical, Moriyama, Japan | Powder: zirconium oxide filler, SiO2 filler, and polymerization initiators; Liquid: 60% 4-META, 40% HEMA, dimethacrylates | |
Epiphany (Nawal et al. [91]) | Pentron Clinical Technologies, Wallingford, CT, USA | UDMA, PEGDMA, EBPADMA, BisGMA, silane-treated barium-borosilicate glasses, barium sulfate, silica, calcium hydroxide, bismuth oxychloride with amines, peroxide, photo initiator, stabilizers, pigment | |
Silicone | GuttaFlow [91] | Coltene/Whaledent, DPI, Mumbai, India | Paste A (sealer): poly-dimethyl polymethyl hydrogen siloxane, silicone oil, paraffin oil, zirconium dioxide, platin catalyst; Paste B (powder): gutta percha (0.9 μm), zinc oxide, barium sulphate, nanosilver particles (as a preservative) |
CP | Apatite root sealer (Al-Haddad and Che Ab Aziz ZA [92]) | Dentsply Sankin, Tokyo, Japan | Powder: alpha tricalcium phosphate, hydroxyapatite, iodoform; Liquid: polyacrylic acid, water |
CS | iRoot SP [59] | Innovative Bioceramix, Vancouver, BC, Canada | Zirconium oxide, calcium silicates, calcium phosphate monobasic, calcium hydroxide, filler, thickening agent |
MTA Fllapex [M] | Angelus, Londrina, PR, Brazil | Paste A: salicylate resin, bismuth trioxide, fumed silica; Paste B: fumed silica, titanium dioxide, MTA (40%, tricalcium silicate, dicalcium silicate, calcium oxide, tricalcium aluminate), base resin (pentaerythritol, rosinate, p-toluenesulfonamide) | |
EndoSequence BC [M] | Brasseler, Savannah, GA, USA | Zirconium oxide 35%–45%, dicalcium silicate 7%–15%, tricalcium silicate 20%–35%, calcium hydroxide 1%–4%, fillers | |
TotalFill BC [M] | FKG Dentaire, La Chaux-de-Fonds, Switzerland | Zirconium oxide 35%–45%, dicalcium silicate 7%–15%, tricalcium silicate 20%–35%, calcium hydroxide 1%–4%, fillers | |
Bioroot RCS [59] | Septodont, Saint-Maur-des-Fossés, France | Powder: tricalcium silicate, zirconium oxide and excipients; Aqueous solution: calcium chloride and excipients | |
Endoseal MTA [M] | Maruchi, Wonju, Korea | Calcium silicate, calcium aluminates, calcium aluminoferrite, calcium sulfates, radiopacifier, thickening agent | |
Endo CPM [M] | EGEO S.R.L. Bajo Licencia MTM Argentina S.A., Buenos Aires, Argentina | MTA: silicon dioxide, calcium carbonate, bismuth trioxide, barium sulfate, propylene glycol alginate, sodium citrate, calcium chloride, active ingredients | |
Nano Ceramic Sealer (Collado-González et al. [63]) | B&L Biotech, Fairfax, VA, USA | Calcium silicate, zirconium oxide, filler, thickening agent |
Material (CS) | Method | Compared material | Dimensional stability |
---|---|---|---|
BioRoot RCS | Distilled water | AH Plus (ER), Pulp Canal Sealer (ZOE), MTA Fillapex (CS) | Water sorption: BioRoot RCS > MTA Fillapex > Pulp Canal Sealer > AH Plus (Siboni, et al. [24]) |
Distilled water | Sealapex (CH), AH Plus (ER), EasySeal (ER), Pulp Canal Sealer (ZOE), N2 (ZOE), TotalFill BC (CS), MTA Fillapex (CS) | Solubility: TotalFill BC Sealer = BioRoot RCS > MTA Fillapex > N2 = Sealapex > Easyseal > Pulp Canal Sealer > AH Plus (Poggio et al. [31]) | |
PBS, Distilled water | AH Plus (ER), MTA Fillapex (CS) | Solubility: MTA Fillapex > BioRoot RCS > AH Plus (Urban et al. [22]) | |
Distilled water | AH Plus (ER), Sealapex (CH), EasySeal (ER), TotalFill BC (CS), MTA Fillapex (CS) | Solubility: TotalFill BC Sealer > BioRoot RCS > MTA Fillapex > Sealapex > Easy Seal > AH Plus (Colombo et al. [32]) | |
PBS, Distilled water | AH Plus (ER), MTA Fillapex (CS) | Solubility: BioRoot RCS > MTA Fillapex > AH Plus (Prüllage et al. [33]) | |
iRoot SP | Distilled water | Sealapex (CH), EndoREZ (MR), AH Plus (ER) | Water sorption: EndoREZ > iRoot SP > Sealapex > AH Plus; Solubility: Sealapex > iRoot SP = EndoREZ = AH Plus (Ersahan and Aydin [30]) |
Distilled water | AH Plus (ER), Sealapex (CH), MTA-Angelus (CS), MTA Fillapex (CS) | Solubility: iRoot SP > MTA Fillapex > Sealapex > MTA Angelus = AH Plus (Borges et al. [28]) | |
EndoSequence BC | Distilled water | MTA Fillapex (CS), AH Plus (ER), ThermaSeal (ER), GuttaFlow (silicone), Pulp Canal Sealer (ZOE) | Solubility: EndoSequence BC sealer > MTA Fillapex > Pulp Canal Sealer > AH Plus > GuttaFlow > ThermaSeal (Zhou et al. [29]) |
MTA Fillapex | Distilled water | AH Plus (ER) | Solubility, water sorption: AH Plus > MTA Fillapex (Vitti et al. [25]) |
Material (CS) | Method | Compared material | Sealing ability |
---|---|---|---|
BioRoot RCS | Single cone | AH 26 (ER) | Dentin penetration: BioRoot RCS > AH 26 (Uzunoglu-Özyürek et al. [93]) |
Lateral compaction | AH Plus (ER) | μCT void: AH Plus < BioRoot RCS; Fluid transport: BioRoot RCS = AH Plus (Viapiana et al. [94]) | |
Single cone, Continuous wave | Endoseal MTA (CS), AH Plus (ER) | Dentin penetration: AH Plus > BioRoot RCS > Endoseal (Kim et al. [35]) | |
Endoseal MTA | Single cone, Continuous wave | AH-Plus (ER), GuttaFlow (silicone) | Bacterial leakage: GuttaFlow > Endoseal MTA = AH Plus (Hwang et al. [95]) |
EndoSequence BC | Single cone, Lateral compaction | AH 26 (ER), EndoREZ (MR) | Fluid transport: AH 26, EndoRez < EndoSequence BC Sealer (Deniz Sungur et al. [96]) |
Single cone, Continuous wave | AH 26 (ER) | Endotoxin leakage: EndoSequence BC sealer > AH 26 (Oh et al. [97]) | |
Continuous wave | AH Plus (ER), Epiphany (ER), MTA Plus (CS) | Dye penetration: EndoSequence BC sealer = Epiphany < AH Plus (Pawar et al. [37]) | |
Lateral compaction | Sealapex (CH), AH Plus (ER), EndoREZ (MR) | Dye penetration: Endosequence BC sealer < EndoRez < Sealapex = MTA Plus < AH plus (Ballullaya et al. [36]) | |
iRoot SP | Lateral compaction | Sealapex (CH), EndoREZ (MR), AH Plus (ER) | Fluid transport: iRoot SP = AH Plus < EndoREZ = Sealapex (Ersahan and Aydin [30]) |
Single cone, Continuous wave | AH Plus (ER) | Fluid transport: iRoot SP = AH Plus (Zhang et al. [48]) | |
Single cone, Continuous wave | Topseal (ER) | Penentration of sealer: iRoot SP < Topseal; Penetration of sealer: Single-point technique < Continuous wave of condensation (Fernández et al. [49]) | |
Lateral compaction | MTA Fillapex (CS) | Fluid transport: iRoot SP < MTA Fillapex (Bidar et al. [98]) | |
Lateral compaction | Hybrid Root SEAL (MR), EndoREZ (ER), AH Plus (ER) | Fluid transport: AH Plus = EndoREZ < iRoot SP < Hybrid Root SEAL (Ulusoy et al. [99]) | |
MTA Fillapex | Warm vertical compaction | AH Plus (ER) | Fluid transport: AH Plus < MTA Fillapex after 7 days, AH Plus > MTA Fillapex after 4 weeks (Asawaworarit et al. [23]) |
Material (CS) | Method | Compared material | Push-out bond strength |
---|---|---|---|
BioRoot RCS | Single cone | AH Plus (ER), GuttaFlow2 (silicone) | AH Plus > BioRoot RCS > GuttaFlow 2 (Donnermeyer et al. [100]) |
Endoseal MTA | No obturation | AH Plus (ER), MTA Fillapex (CS) | AH Plus > Endoseal MTA > MTA Fillapex (Silva et al. [101]) |
EndoSequence BC | Lateral compaction, Thermoplasticized injection technology | AH Plus (ER), MTA Plus Sealer (CS) | AH Plus > EndoSequence BC sealer; lateral compaction > Thermoplasticized injection (Dabaj et al. [55]) |
Single cone, Continuous wave | AH Plus (ER) | EndoSequence BC sealer = AH Plus > MTA Plus; Single cone > Continuous wave (DeLong et al. [51]) | |
iRoot SP | No obturation | AH Plus (ER), EndoREZ (ER), Sealapex (CH) | iRoot SP = AH Plus > EndoREZ = Sealapex (Ersahan and Aydin [102]) |
Single cone | RealSeal SE (MR), AH Plus (ER), MTA Fillapex (CS) | AH Plus = iRoot SP > MTA Fillapex > RealSeal SE (Nagas et al. [50]) | |
BioRoot RCS | No obturation | TotalFill BC (CS), AH Plus (ER), Endo CPM (CS) | AH Plus > TotalFill BC Sealer > BioRoot RCS > Endo CPM Sealer (Donnermeyer et al. [20,21]) |
Material | Cells used | Compared material | Biocompatibility |
---|---|---|---|
iRoot SP | L929 mouse fibroblasts | AH Plus (ER), ProRoot MTA | ProRoot MTA > iRoot SP > AH Plus (Zhang et al. [57]) |
MG 63 human osteoblast-like cells | AH Plus (ER) | iRoot SP: non-toxic, AH Plus: slightly cytotoxic (Zhang et al. [85]) | |
hTGSCs | ProRoot MTA, Dycal (CH) | ProRoot MTA and iRoot SP: no cytotoxicity, Dycal: cytotoxicity (Güven et al. [87]) | |
hPDL | Sealapex (CH), Apatite root sealer (CP), MTA Fillapex (CS) | None of the sealers were cytotoxic (Chang et al. [58]) | |
EndoSequence BC | MC3T3-E1 mouse osteoblast cells | AH Plus (ER), Pulp Canal Sealer (ZOE) | AH Plus > EndoSequence BC > Pulp Canal Sealer (Loushine et al. [69]) |
AH Plus (ER), MTA Fillapex (CS) | EndoSequence BC, MTA Fillapex > AH plus (Lee et al. [70]) | ||
Human gingival fibroblasts | MTA Fillapex (CS), AH Plus (ER) | EndoSequence BC > AH plus > MTA Fillapex, AH Plus was cytotoxic as freshly mixed (Zhou et al. [65]) | |
Balb/c3T3 mouse fibroblast | Endoseal MTA, MTA Fillapex (CS), AH Plus (ER) | Endoseal MTA, EndoSequence BC Sealer and AH Plus: similar cell viability, MTA Fillapex sealer: cytotoxic (da Silva et al. [67]) | |
BioRoot RCS | hPDL | MTA-Fillapex, TotalFill BC (CS), GuttaFlow 2 (siolicone), AH Plus (ER), Roth's 801 (ZOE) | GuttaFlow 2 > TotalFill > BioRoot > MTA Fillapex > AH Plus > Roth's 801 (Taraslia et al. [61]) |
MTA Fillapex (CS), AH Plus (ER), Pulp Canal Sealer (ZOE) | Bioroot RCS > AH Plus > MTA Fillapex, Pulp Canal Sealer (Jung et al. [60]) | ||
AH Plus Jet, Acroseal (ER), EndoREZ, RealSeal, RealSeal SE, Hybrid Root Seal (MR), iRootSP, MTA Fillapex (CS) | BioRoot RCS > iRoot SP > MTA Fillapex > EndoREZ > AH Plus Jet > RealSeal SE > Acroseal > Realseal > Hybrid Root seal (Eldeniz et al. [59]) | ||
HGF-1 (ATCC CRL-2014) | TotalFill BC, MTA Fillapex (CS), Sealapex (CH), AH Plus, EasySeal (ER), Pulp Canal Sealer, N2 (ZOE) | BioRoot RCS, TotalFill BC Sealer and AH Plus: no cytotoxic effects in the first 24 hr, All the other sealers: cytotoxic (Poggio et al. [31]) | |
EasySeal, AH Plus (ER), SealapexTM (CH), MTA Fillapex, TotalFill BC (CS) | BioRoot RCS, TotalFill BC > AH Plus, Sealapex TM > EasySeal, MTA Fillapex (Colombo et al. [32]) | ||
Human bone marrow mesenchymal stem cells | EndoSequence BC (CS), AH Plus (ER) | BioRoot RCS, Endosequece BC > AH Plus (Alsubait et al. [103]) | |
Endoseal MTA | MC3T3-E1 mouse osteoblast cells | ProRoot MTA, AH plus (ER) | ProRoot MTA, Endosael MTA > AH Plus (Lim et al. [104]) |
hPDLSCs | Bioroot RCS, Endoseal MTA, Nano Ceramic Sealer (CS) | Bioroot RCS, Nano Ceramic Sealer > Endoseal MTA (Collado-González et al. [63]) | |
Human gingival fibroblast | AH Plus (ER), MTA Fillapex, BioRoot RCS (CS) | MTA Fillapex > Bioroot RCS > AH plus > Endoseal MTA (Kebudi Benezra et al. [64]) |
Material | Compared material (based material) | Test method | Sealer setting | Evaluation time | Antibacterial effect against E. faecalis |
---|---|---|---|---|---|
iRoot SP | AH Plus (ER), Epiphany, EndoRez (MR), Apexit Plus, Sealapex (CH), Tubli Seal EWT (ZOE) | DCT | Fresh, 1, 3, and 7 days | 2–60 min | Fresh: iRoot SP, AH Plus, EndoRez, Sealapex, Epiphany; 1 day and 3 days: iRoot SP, EndoRez > Sealapex, Epiphany; 7 days: EndoRez, Sealapex (Zhang et al. [71]) |
AH Plus (ER), Tubliseal EWT (ZOE), EndoRez (MR) | DCT | 20 min | Every 30 min up to 18 hr | AH Plus, iRoot SP (Nirupama et al. [81]) | |
EndoSequence BC | AH Plus (ER) | ADT | Fresh | 48 hr | AH Plus > EndoSequence BC (Candeiro et al. [77]) |
DCT | Fresh | 1, 24, 72, 168 hr | AH Plus > EndoSequence BC up to 1 hr, after 1 hr, similar effects [77] | ||
AH Plus (ER), Pulp Canal Sealer (ZOE) | CLSM | Fresh | 1, 7, 30 days | EndoSequence BC, AH Plus > Pulp Canal Sealer (Wang et al. [79]) | |
GuttaFlow (silicone), Pulp Canal Sealer (ZOE), AH Plus Jet (ER) | SEM | 24 hr | 24 hr | Pulp Canal Sealer (Willershausen et al. [83]) | |
BioRootRCS | MTA Fillapex (CS), AH Plus (ER) | ADT | 24 hr | 24 hr | Bioroot RCS, AH Plus > MTA Fillapex (Arias-Moliz and Camilleri [78]) |
CLSM | 24 hr | 7 days | BioRoot RCS > MTA Fillapex > AH Plus [78] | ||
TotalFill BC (CS), AH Plus (ER) | CLSM | Fresh | 1, 7, 30 days | BioRoot RCS > TotalFill BC, AH Plus after 30 days (Alsubait et al. [80]) | |
EasySeal, AH Plus (ER), SealapexTM (CH), TotalFill BC, MTA Fillapex (CS) | ADT | Fresh | 48 hr | EasySeal > AH Plus > BioRoot RCS, Sealapex, MTA Fillapex (Colombo et al. [32]) | |
DCT | 7 day | 6, 15, 60 min | 6 min: TotalFill BC, Easyseal > Bioroot RCS > MTA Fillapex | ||
15, 60 min: BioRoot RCS, TotalFill BC, EasySeal > MTA Fillapex, Sealapex > AH Plus (Colombo et al. [32]) | |||||
Endoseal MTA | AH Plus (ER), Sealapex (CH), Tubli-Seal (ZOE), EndoSequence BC (CS) | DCT | Before and after setting | 24 hr | Endoseal MTA > Sealapex > TubliSeal > AH Plus > EndoSequence BC |
All sealers had less effect after setting (Shin et al. [82]) |
Material | Compared material | Cells used | Mineralization potential |
---|---|---|---|
iRoot SP | AH Plus (ER) | MG 63 human osteoblast-like cells | COL 1, OCN and BSP mRNA expression up-regulation: iRoot SP > AH Plus (Zhang et al. [85]) |
ProRoot MTA, Dycal (CH) | hTGSCs | COL 1A and DSPP mRNA expression: MTA > iRoot SP (Güven et al. [87]) | |
Sealapex (CH), Apatite root sealer (CP), MTA Fillapex (CS) | Human PDL cells | ALP, mineralization nodule up-regulation: all sealers except for Sealapex; ON, OPN, OCN, Osterix, Runx2: MTA Fillapex > Apatitie root sealer > iRoot SP > Sealapex (Chang et al. [58]) | |
EndoSequence BC | AH Plus (ER), MTA Fillapex (CS) | MC3T3-E1 mouse osteoblast cells | All sealers increased ALP, OCN and alizarin red staining mineral: Calcium silicate sealers > AH Plus (Lee et al. [70]) |
BioRoot RCS | Pulp Canal Sealer (ZOE) | hPDL, Mouse pulp-derived stem cell line A4 | BMP2, TGF2: BioRoot RCS > Pulp Canal Sealer (Camps et al. [86]); VEGF: BioRoot = Pulp Canal Sealer (Camps et al. [86]); COL1, DMP1, BSP expression: BioRoot RCS preserved the intrinsic ability, but Pulp Canal Sealer reduced the ability (Dimitrova-Nakov et al. [89]) |
AH Plus (ER), MTA Fillapex (CS), Pulp Canal Sealer (ZOE) | Calcium release, pH, nucleation of CaP after aging 28 day | BioRoot RCS > MTA Fillapex > AH Plus > Pulp Canal Sealer (Siboni et al. [24]) | |
Biodentine | Human dental pulp stem cell | Both of them; Mineralization matrix induction: up-regulation; ALP, COL A1, OPN: down-regulation; Runx2: unmodified; Nestin, Msx2: up-regulation; DSPP expressed in direct contact with Biodentine, but BioRoot RCS needed mineralizing conditions, i.e., phosphate ions (Loison-Robert et al. [88]) | |
Endoseal MTA | ProRoot MTA | Intratubular biomineralization | Endoseal MTA enhanced biomineralization of dentinal tubules (Yoo et al. [90]) |
Funding: This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government (NRF-2019R1C1C1003240).
Conflict of Interest: No potential conflict of interest relevant to this article was reported.
Author Contributions:
Conceptualization: Lim M, Jung C.
Data curation: Lim M, Jung C.
Funding acquisition: Song M.
Investigation: Lim M, Jung C.
Methodology: Lim M, Jung C, Song M.
Project administration: Lim M, Jung C, Song M.
Resources: Lim M, Jung C, Song M.
Supervision: Cho YB, Shin DH.
Writing - original draft: Lim M, Jung C, Song M.
Writing - review & editing: Cho YB, Shin DH, Song M.
Material base | Products | Manufacturer | Composition |
---|---|---|---|
ZOE | Roth's 801 [M] | Roth International, Miami, FL, USA | Powder: zinc oxide, staybelite resin, bismuth sub-carbonate, barium sulfate, sodium borate; Liquid: eugenol |
Pulp Canal sealer [M] | Kerr, Orange, CA, USA | Powder: zinc oxide 30%–60%, 5,5′-diisopropyl-2,2′-dimethylbiphenyl-4,4′-diyl dihypoiodite 0.1%–5%; Liquid: eugenol 60%–90%, Canada balsam 10%–30% | |
Tubli Seal [M] | Kerr, Orange, CA, USA | Base: zinc oxide 60%–100%, white mineral oil (petroleum) 10%–30%; Accelerator: eugenol 30%–60%, 5,5′-diisopropyl-2,2′-dimethylbiphenyl-4,4′-diyl dihypoiodite 5%–10% | |
Endo N2 [M] | Ghimas, Casalecchio di Reno, Italy | Powder: zinc oxide 65.68%, nitrate bismuth 15.17%, carbonate bismuth 10.1%, paraformaldehyde 4%, titanium dioxide 4.76%, red ferric oxide 0.1%, zinc stearate 0.075%, dehydrate zinc acetate 0.075%, yellow ferric oxide 0.04%; Liquid: eugenol 77%, peanut oil 20%, rose oil 1.8%, lavender oil 1.2% | |
CH | Sealapex root canal sealer [M] | Kerr, Orange, CA, USA | Base: N-ethyl-o (or p)-toluenesulfonamide 30%–60%, calcium oxide 30%–60%, zinc oxide 1%–5%, zinc distearate 1%–5%; Catalyst: methyl salicylate 10%–30%, 2,2 dimethylpropane-1,3-diol 1%–5%, isobutyl salicylate 1%–5% |
Apexit Plus [M] | Ivoclar Vivadent AG, Schaan, Liechtenstein | Base: calcium hydroxide/calcium oxide 36.9%, hydrated colophonium 54%, fillers and other auxiliary materials 9.1%; Activator: disalicylate 47.6%, bismuth hydroxide/bismuth carbonate 36.4%, fillers and other auxiliary materials 16% | |
ER | AH 26 [M] | Dentsply DeTrey, Konstanz, Germany | Powder: methenamine 25%–50%, titanium dioxide 2.5%–10%, silver 2.5%; Liquid: bisphenol A/epichlorohydrin resin 50%–100% |
AH Plus [M] | Dentsply DeTrey, Konstanz, Germany | Paste A: bisphenol A diglycidylether 25%–50%, bis-[4-(-2,3-epoxypropoxy) phenyl]-methane 2.5%–10%; Paste B: N,N′-dibenzyl-5-oxanonandiamin-1,9 10%–25%, amantadine 2.5%–10% | |
Acroseal [M] | Septodont, Saint-Maur-des-Fossés, France | Base: resin acids, hydrogenated 25%–50%, TCD-diamine 10%–25%; Catalyst: bisphenol-A-(epichlorohydrin) epoxy resin 50%–100%, calcium dihydroxide 10%–25% | |
Easyseal [M] | Komet Brasseler, GmbH Co., Lemgo, Germany | Paste 1: 4-[-2-(4-hydroxyphenyl) propan-2-yl] phenol-epichlorohydrine resin, alkylglycidyl ether, barium sulfate, tricalcium phosphate, diphenylolpropane-diglycidyl ether; Paste 2: polyalkoxyalkylamine-copolymer, 5-amino-1,3,3-trimethylcyclohexanmethylamine, aqua, barium sulfate, tricalcium phosphate, nanodispers silicone dioxide, polyhexamethylene biguanides-hydrochloride | |
Theramseal [M] | Dentsply Meillefer, Konstanz, Germany | Paste A: epoxy resin, calcium tungstate, zirconium oxide, aerosol, iron oxide; Paste B: Adamantane amine, N,N′-dibenzyl-5-oxanonandiamin-1,9, TCD-diamine, calcium tungstate, zirconium oxide aerosol, silicone oil | |
Topseal [M] | Dentsply Meillefer, Ballaigues, Switzerland | Paste A: epoxy resin, calcium tungstate, zirconium oxide, aerosol, iron oxide; Paste B: adamantane amine, N,N′-dibenzyl-5-oxanonandiamin-1,9, TCD-diamine, calcium tungstate, zirconium oxide aerosol, silicone oil | |
MR | Endorez [M] | Ultradent Product Inc., South Jordan, UT, USA | Base: diurethane dimethacrylate > 10 and ≤ 25%, triethylene glycol dimethacrylate > 10 and ≤ 25%, organophosphine oxide ≤ 2.5%, benzoyl peroxide ≤ 2.5%; Catalyst: diurethane dimethacrylate > 25 and ≤ 50%, triethylene glycol dimethacrylate > 10 and ≤ 25% |
RealSeal (Eldeniz et al. [ | SybronEndo, Orange, CA, USA | PEGDMA, EBPADMA, EDMA, BisGMA, silane-treated barium borosilicate glasses, barium sulphate, silica, calcium hydroxide, bismuth oxychloride with amines, peroxide, photoinitiator, stabilizers, pigment | |
RealSeal SE [ | SybronEndo, Orange, CA, USA | EBPADMA, HEMA, BisGMA, acidic methacrylate resins, barium borosilicate glasses, silica, hydroxyapatite, Ca-Al-F-silicate, bismuth oxychloride with amines, peroxide, photoinitiator, stabilizers, pigment, aluminium oxide | |
Hybrid Root Seal [ | Sun Medical, Moriyama, Japan | Powder: zirconium oxide filler, SiO2 filler, and polymerization initiators; Liquid: 60% 4-META, 40% HEMA, dimethacrylates | |
Epiphany (Nawal et al. [ | Pentron Clinical Technologies, Wallingford, CT, USA | UDMA, PEGDMA, EBPADMA, BisGMA, silane-treated barium-borosilicate glasses, barium sulfate, silica, calcium hydroxide, bismuth oxychloride with amines, peroxide, photo initiator, stabilizers, pigment | |
Silicone | GuttaFlow [ | Coltene/Whaledent, DPI, Mumbai, India | Paste A (sealer): poly-dimethyl polymethyl hydrogen siloxane, silicone oil, paraffin oil, zirconium dioxide, platin catalyst; Paste B (powder): gutta percha (0.9 μm), zinc oxide, barium sulphate, nanosilver particles (as a preservative) |
CP | Apatite root sealer (Al-Haddad and Che Ab Aziz ZA [ | Dentsply Sankin, Tokyo, Japan | Powder: alpha tricalcium phosphate, hydroxyapatite, iodoform; Liquid: polyacrylic acid, water |
CS | iRoot SP [ | Innovative Bioceramix, Vancouver, BC, Canada | Zirconium oxide, calcium silicates, calcium phosphate monobasic, calcium hydroxide, filler, thickening agent |
MTA Fllapex [M] | Angelus, Londrina, PR, Brazil | Paste A: salicylate resin, bismuth trioxide, fumed silica; Paste B: fumed silica, titanium dioxide, MTA (40%, tricalcium silicate, dicalcium silicate, calcium oxide, tricalcium aluminate), base resin (pentaerythritol, rosinate, p-toluenesulfonamide) | |
EndoSequence BC [M] | Brasseler, Savannah, GA, USA | Zirconium oxide 35%–45%, dicalcium silicate 7%–15%, tricalcium silicate 20%–35%, calcium hydroxide 1%–4%, fillers | |
TotalFill BC [M] | FKG Dentaire, La Chaux-de-Fonds, Switzerland | Zirconium oxide 35%–45%, dicalcium silicate 7%–15%, tricalcium silicate 20%–35%, calcium hydroxide 1%–4%, fillers | |
Bioroot RCS [ | Septodont, Saint-Maur-des-Fossés, France | Powder: tricalcium silicate, zirconium oxide and excipients; Aqueous solution: calcium chloride and excipients | |
Endoseal MTA [M] | Maruchi, Wonju, Korea | Calcium silicate, calcium aluminates, calcium aluminoferrite, calcium sulfates, radiopacifier, thickening agent | |
Endo CPM [M] | EGEO S.R.L. Bajo Licencia MTM Argentina S.A., Buenos Aires, Argentina | MTA: silicon dioxide, calcium carbonate, bismuth trioxide, barium sulfate, propylene glycol alginate, sodium citrate, calcium chloride, active ingredients | |
Nano Ceramic Sealer (Collado-González et al. [ | B&L Biotech, Fairfax, VA, USA | Calcium silicate, zirconium oxide, filler, thickening agent |
ZOE, zinc oxide-eugenol; CH, calcium hydroxide; ER, epoxy resin; MR, methacrylate resin; CP, calcium phosphate; CS, calcium silicate; M, provided from manufacturer; 4‐META, 4‐methacryloxyethyl trimellitic anhydride; HEMA, 2‐hydroxyethyl methacrylate; TCD, tricyclodecane; PEGDMA, polyethylene glycol dimethacrylate; EBPADMA, ethoxylated bisphenol A dimethacrylate; EDMA, 3,4-ethylenedioxy-N-methylamphetamine; BisGMA, bisphenol A-glycidyl methacrylate; UDMA, urethane dimethylate.
Material (CS) | Method | Compared material | Dimensional stability |
---|---|---|---|
BioRoot RCS | Distilled water | AH Plus (ER), Pulp Canal Sealer (ZOE), MTA Fillapex (CS) | Water sorption: BioRoot RCS > MTA Fillapex > Pulp Canal Sealer > AH Plus (Siboni, et al. [ |
Distilled water | Sealapex (CH), AH Plus (ER), EasySeal (ER), Pulp Canal Sealer (ZOE), N2 (ZOE), TotalFill BC (CS), MTA Fillapex (CS) | Solubility: TotalFill BC Sealer = BioRoot RCS > MTA Fillapex > N2 = Sealapex > Easyseal > Pulp Canal Sealer > AH Plus (Poggio et al. [ | |
PBS, Distilled water | AH Plus (ER), MTA Fillapex (CS) | Solubility: MTA Fillapex > BioRoot RCS > AH Plus (Urban et al. [ | |
Distilled water | AH Plus (ER), Sealapex (CH), EasySeal (ER), TotalFill BC (CS), MTA Fillapex (CS) | Solubility: TotalFill BC Sealer > BioRoot RCS > MTA Fillapex > Sealapex > Easy Seal > AH Plus (Colombo et al. [ | |
PBS, Distilled water | AH Plus (ER), MTA Fillapex (CS) | Solubility: BioRoot RCS > MTA Fillapex > AH Plus (Prüllage et al. [ | |
iRoot SP | Distilled water | Sealapex (CH), EndoREZ (MR), AH Plus (ER) | Water sorption: EndoREZ > iRoot SP > Sealapex > AH Plus; Solubility: Sealapex > iRoot SP = EndoREZ = AH Plus (Ersahan and Aydin [ |
Distilled water | AH Plus (ER), Sealapex (CH), MTA-Angelus (CS), MTA Fillapex (CS) | Solubility: iRoot SP > MTA Fillapex > Sealapex > MTA Angelus = AH Plus (Borges et al. [ | |
EndoSequence BC | Distilled water | MTA Fillapex (CS), AH Plus (ER), ThermaSeal (ER), GuttaFlow (silicone), Pulp Canal Sealer (ZOE) | Solubility: EndoSequence BC sealer > MTA Fillapex > Pulp Canal Sealer > AH Plus > GuttaFlow > ThermaSeal (Zhou et al. [ |
MTA Fillapex | Distilled water | AH Plus (ER) | Solubility, water sorption: AH Plus > MTA Fillapex (Vitti et al. [ |
CS, calcium silicate; ER, epoxy resin; ZOE, zinc oxide-eugenol; CH, calcium hydroxide; MR, methacrylate resin.
Material (CS) | Method | Compared material | Sealing ability |
---|---|---|---|
BioRoot RCS | Single cone | AH 26 (ER) | Dentin penetration: BioRoot RCS > AH 26 (Uzunoglu-Özyürek et al. [ |
Lateral compaction | AH Plus (ER) | μCT void: AH Plus < BioRoot RCS; Fluid transport: BioRoot RCS = AH Plus (Viapiana et al. [ | |
Single cone, Continuous wave | Endoseal MTA (CS), AH Plus (ER) | Dentin penetration: AH Plus > BioRoot RCS > Endoseal (Kim et al. [ | |
Endoseal MTA | Single cone, Continuous wave | AH-Plus (ER), GuttaFlow (silicone) | Bacterial leakage: GuttaFlow > Endoseal MTA = AH Plus (Hwang et al. [ |
EndoSequence BC | Single cone, Lateral compaction | AH 26 (ER), EndoREZ (MR) | Fluid transport: AH 26, EndoRez < EndoSequence BC Sealer (Deniz Sungur et al. [ |
Single cone, Continuous wave | AH 26 (ER) | Endotoxin leakage: EndoSequence BC sealer > AH 26 (Oh et al. [ | |
Continuous wave | AH Plus (ER), Epiphany (ER), MTA Plus (CS) | Dye penetration: EndoSequence BC sealer = Epiphany < AH Plus (Pawar et al. [ | |
Lateral compaction | Sealapex (CH), AH Plus (ER), EndoREZ (MR) | Dye penetration: Endosequence BC sealer < EndoRez < Sealapex = MTA Plus < AH plus (Ballullaya et al. [ | |
iRoot SP | Lateral compaction | Sealapex (CH), EndoREZ (MR), AH Plus (ER) | Fluid transport: iRoot SP = AH Plus < EndoREZ = Sealapex (Ersahan and Aydin [ |
Single cone, Continuous wave | AH Plus (ER) | Fluid transport: iRoot SP = AH Plus (Zhang et al. [ | |
Single cone, Continuous wave | Topseal (ER) | Penentration of sealer: iRoot SP < Topseal; Penetration of sealer: Single-point technique < Continuous wave of condensation (Fernández et al. [ | |
Lateral compaction | MTA Fillapex (CS) | Fluid transport: iRoot SP < MTA Fillapex (Bidar et al. [ | |
Lateral compaction | Hybrid Root SEAL (MR), EndoREZ (ER), AH Plus (ER) | Fluid transport: AH Plus = EndoREZ < iRoot SP < Hybrid Root SEAL (Ulusoy et al. [ | |
MTA Fillapex | Warm vertical compaction | AH Plus (ER) | Fluid transport: AH Plus < MTA Fillapex after 7 days, AH Plus > MTA Fillapex after 4 weeks (Asawaworarit et al. [ |
CS, calcium silicate; ER, epoxy resin; μCT, micro-computed tomography; CH, calcium hydroxide; MR, methacrylate resin.
Material (CS) | Method | Compared material | Push-out bond strength |
---|---|---|---|
BioRoot RCS | Single cone | AH Plus (ER), GuttaFlow2 (silicone) | AH Plus > BioRoot RCS > GuttaFlow 2 (Donnermeyer et al. [ |
Endoseal MTA | No obturation | AH Plus (ER), MTA Fillapex (CS) | AH Plus > Endoseal MTA > MTA Fillapex (Silva et al. [ |
EndoSequence BC | Lateral compaction, Thermoplasticized injection technology | AH Plus (ER), MTA Plus Sealer (CS) | AH Plus > EndoSequence BC sealer; lateral compaction > Thermoplasticized injection (Dabaj et al. [ |
Single cone, Continuous wave | AH Plus (ER) | EndoSequence BC sealer = AH Plus > MTA Plus; Single cone > Continuous wave (DeLong et al. [ | |
iRoot SP | No obturation | AH Plus (ER), EndoREZ (ER), Sealapex (CH) | iRoot SP = AH Plus > EndoREZ = Sealapex (Ersahan and Aydin [ |
Single cone | RealSeal SE (MR), AH Plus (ER), MTA Fillapex (CS) | AH Plus = iRoot SP > MTA Fillapex > RealSeal SE (Nagas et al. [ | |
BioRoot RCS | No obturation | TotalFill BC (CS), AH Plus (ER), Endo CPM (CS) | AH Plus > TotalFill BC Sealer > BioRoot RCS > Endo CPM Sealer (Donnermeyer et al. [ |
CS, calcium silicate; ER, epoxy resin; CH, calcium hydroxide; MR, methacrylate resin.
Material | Cells used | Compared material | Biocompatibility |
---|---|---|---|
iRoot SP | L929 mouse fibroblasts | AH Plus (ER), ProRoot MTA | ProRoot MTA > iRoot SP > AH Plus (Zhang et al. [ |
MG 63 human osteoblast-like cells | AH Plus (ER) | iRoot SP: non-toxic, AH Plus: slightly cytotoxic (Zhang et al. [ | |
hTGSCs | ProRoot MTA, Dycal (CH) | ProRoot MTA and iRoot SP: no cytotoxicity, Dycal: cytotoxicity (Güven et al. [ | |
hPDL | Sealapex (CH), Apatite root sealer (CP), MTA Fillapex (CS) | None of the sealers were cytotoxic (Chang et al. [ | |
EndoSequence BC | MC3T3-E1 mouse osteoblast cells | AH Plus (ER), Pulp Canal Sealer (ZOE) | AH Plus > EndoSequence BC > Pulp Canal Sealer (Loushine et al. [ |
AH Plus (ER), MTA Fillapex (CS) | EndoSequence BC, MTA Fillapex > AH plus (Lee et al. [ | ||
Human gingival fibroblasts | MTA Fillapex (CS), AH Plus (ER) | EndoSequence BC > AH plus > MTA Fillapex, AH Plus was cytotoxic as freshly mixed (Zhou et al. [ | |
Balb/c3T3 mouse fibroblast | Endoseal MTA, MTA Fillapex (CS), AH Plus (ER) | Endoseal MTA, EndoSequence BC Sealer and AH Plus: similar cell viability, MTA Fillapex sealer: cytotoxic (da Silva et al. [ | |
BioRoot RCS | hPDL | MTA-Fillapex, TotalFill BC (CS), GuttaFlow 2 (siolicone), AH Plus (ER), Roth's 801 (ZOE) | GuttaFlow 2 > TotalFill > BioRoot > MTA Fillapex > AH Plus > Roth's 801 (Taraslia et al. [ |
MTA Fillapex (CS), AH Plus (ER), Pulp Canal Sealer (ZOE) | Bioroot RCS > AH Plus > MTA Fillapex, Pulp Canal Sealer (Jung et al. [ | ||
AH Plus Jet, Acroseal (ER), EndoREZ, RealSeal, RealSeal SE, Hybrid Root Seal (MR), iRootSP, MTA Fillapex (CS) | BioRoot RCS > iRoot SP > MTA Fillapex > EndoREZ > AH Plus Jet > RealSeal SE > Acroseal > Realseal > Hybrid Root seal (Eldeniz et al. [ | ||
HGF-1 (ATCC CRL-2014) | TotalFill BC, MTA Fillapex (CS), Sealapex (CH), AH Plus, EasySeal (ER), Pulp Canal Sealer, N2 (ZOE) | BioRoot RCS, TotalFill BC Sealer and AH Plus: no cytotoxic effects in the first 24 hr, All the other sealers: cytotoxic (Poggio et al. [ | |
EasySeal, AH Plus (ER), SealapexTM (CH), MTA Fillapex, TotalFill BC (CS) | BioRoot RCS, TotalFill BC > AH Plus, Sealapex TM > EasySeal, MTA Fillapex (Colombo et al. [ | ||
Human bone marrow mesenchymal stem cells | EndoSequence BC (CS), AH Plus (ER) | BioRoot RCS, Endosequece BC > AH Plus (Alsubait et al. [ | |
Endoseal MTA | MC3T3-E1 mouse osteoblast cells | ProRoot MTA, AH plus (ER) | ProRoot MTA, Endosael MTA > AH Plus (Lim et al. [ |
hPDLSCs | Bioroot RCS, Endoseal MTA, Nano Ceramic Sealer (CS) | Bioroot RCS, Nano Ceramic Sealer > Endoseal MTA (Collado-González et al. [ | |
Human gingival fibroblast | AH Plus (ER), MTA Fillapex, BioRoot RCS (CS) | MTA Fillapex > Bioroot RCS > AH plus > Endoseal MTA (Kebudi Benezra et al. [ |
MR, methacrylate resin; ER, epoxy resin; hTGSC, human tooth germ stem cell; CH, calcium hydroxide; hPDL, human periodontal ligament; CP, calcium phosphate; ZOE, zinc oxide-eugenol; CS, calcium silicate; HGF-1, human gingival fibroblast; hPDLSC, human periodontal ligament stem cell.
Material | Compared material (based material) | Test method | Sealer setting | Evaluation time | Antibacterial effect against E. faecalis |
---|---|---|---|---|---|
iRoot SP | AH Plus (ER), Epiphany, EndoRez (MR), Apexit Plus, Sealapex (CH), Tubli Seal EWT (ZOE) | DCT | Fresh, 1, 3, and 7 days | 2–60 min | Fresh: iRoot SP, AH Plus, EndoRez, Sealapex, Epiphany; 1 day and 3 days: iRoot SP, EndoRez > Sealapex, Epiphany; 7 days: EndoRez, Sealapex (Zhang et al. [ |
AH Plus (ER), Tubliseal EWT (ZOE), EndoRez (MR) | DCT | 20 min | Every 30 min up to 18 hr | AH Plus, iRoot SP (Nirupama et al. [ | |
EndoSequence BC | AH Plus (ER) | ADT | Fresh | 48 hr | AH Plus > EndoSequence BC (Candeiro et al. [ |
DCT | Fresh | 1, 24, 72, 168 hr | AH Plus > EndoSequence BC up to 1 hr, after 1 hr, similar effects [ | ||
AH Plus (ER), Pulp Canal Sealer (ZOE) | CLSM | Fresh | 1, 7, 30 days | EndoSequence BC, AH Plus > Pulp Canal Sealer (Wang et al. [ | |
GuttaFlow (silicone), Pulp Canal Sealer (ZOE), AH Plus Jet (ER) | SEM | 24 hr | 24 hr | Pulp Canal Sealer (Willershausen et al. [ | |
BioRootRCS | MTA Fillapex (CS), AH Plus (ER) | ADT | 24 hr | 24 hr | Bioroot RCS, AH Plus > MTA Fillapex (Arias-Moliz and Camilleri [ |
CLSM | 24 hr | 7 days | BioRoot RCS > MTA Fillapex > AH Plus [ | ||
TotalFill BC (CS), AH Plus (ER) | CLSM | Fresh | 1, 7, 30 days | BioRoot RCS > TotalFill BC, AH Plus after 30 days (Alsubait et al. [ | |
EasySeal, AH Plus (ER), SealapexTM (CH), TotalFill BC, MTA Fillapex (CS) | ADT | Fresh | 48 hr | EasySeal > AH Plus > BioRoot RCS, Sealapex, MTA Fillapex (Colombo et al. [ | |
DCT | 7 day | 6, 15, 60 min | 6 min: TotalFill BC, Easyseal > Bioroot RCS > MTA Fillapex | ||
15, 60 min: BioRoot RCS, TotalFill BC, EasySeal > MTA Fillapex, Sealapex > AH Plus (Colombo et al. [ | |||||
Endoseal MTA | AH Plus (ER), Sealapex (CH), Tubli-Seal (ZOE), EndoSequence BC (CS) | DCT | Before and after setting | 24 hr | Endoseal MTA > Sealapex > TubliSeal > AH Plus > EndoSequence BC |
All sealers had less effect after setting (Shin et al. [ |
ER, epoxy resin; MR, methacrylate resin; CH, calcium hydroxide; ZOE, zinc oxide-eugenol; DCT, direct contact test; ADT, agar diffusion test; CLSM, confocal laser scanning microscopy; SEM, scanning electron microscopy; CS, calcium silicate.
Material | Compared material | Cells used | Mineralization potential |
---|---|---|---|
iRoot SP | AH Plus (ER) | MG 63 human osteoblast-like cells | COL 1, OCN and BSP mRNA expression up-regulation: iRoot SP > AH Plus (Zhang et al. [ |
ProRoot MTA, Dycal (CH) | hTGSCs | COL 1A and DSPP mRNA expression: MTA > iRoot SP (Güven et al. [ | |
Sealapex (CH), Apatite root sealer (CP), MTA Fillapex (CS) | Human PDL cells | ALP, mineralization nodule up-regulation: all sealers except for Sealapex; ON, OPN, OCN, Osterix, Runx2: MTA Fillapex > Apatitie root sealer > iRoot SP > Sealapex (Chang et al. [ | |
EndoSequence BC | AH Plus (ER), MTA Fillapex (CS) | MC3T3-E1 mouse osteoblast cells | All sealers increased ALP, OCN and alizarin red staining mineral: Calcium silicate sealers > AH Plus (Lee et al. [ |
BioRoot RCS | Pulp Canal Sealer (ZOE) | hPDL, Mouse pulp-derived stem cell line A4 | BMP2, TGF2: BioRoot RCS > Pulp Canal Sealer (Camps et al. [ |
AH Plus (ER), MTA Fillapex (CS), Pulp Canal Sealer (ZOE) | Calcium release, pH, nucleation of CaP after aging 28 day | BioRoot RCS > MTA Fillapex > AH Plus > Pulp Canal Sealer (Siboni et al. [ | |
Biodentine | Human dental pulp stem cell | Both of them; Mineralization matrix induction: up-regulation; ALP, COL A1, OPN: down-regulation; Runx2: unmodified; Nestin, Msx2: up-regulation; DSPP expressed in direct contact with Biodentine, but BioRoot RCS needed mineralizing conditions, i.e., phosphate ions (Loison-Robert et al. [ | |
Endoseal MTA | ProRoot MTA | Intratubular biomineralization | Endoseal MTA enhanced biomineralization of dentinal tubules (Yoo et al. [ |
ER, epoxy resin; COL, collagen; OCN, osteocalcin; BSP, bone sialoprotein; CH, calcium hydroxide; hTGSC, human tooth germ stem cell; DSPP, dentin sialophosphoprotein; CP, calcium phosphate; CS, calcium silicate; PDL, periodontal ligament; ALP, alkaline phosphatase; ON, osteonectin; OPN, osteopontin; Runx, runt-related transcription factor; ZOE, zinc oxide-eugenol; hPDL, human periodontal ligament; BMP, bone morphogenic protein; TGF, transforming growth factor; VEGF, vascular endothelial growth factor; DMP, dentin matrix protein; BSP, bone sialoprotein; CaP, calcium phosphate; Msx, msh homeobox.
ZOE, zinc oxide-eugenol; CH, calcium hydroxide; ER, epoxy resin; MR, methacrylate resin; CP, calcium phosphate; CS, calcium silicate; M, provided from manufacturer; 4‐META, 4‐methacryloxyethyl trimellitic anhydride; HEMA, 2‐hydroxyethyl methacrylate; TCD, tricyclodecane; PEGDMA, polyethylene glycol dimethacrylate; EBPADMA, ethoxylated bisphenol A dimethacrylate; EDMA, 3,4-ethylenedioxy-N-methylamphetamine; BisGMA, bisphenol A-glycidyl methacrylate; UDMA, urethane dimethylate.
CS, calcium silicate; ER, epoxy resin; ZOE, zinc oxide-eugenol; CH, calcium hydroxide; MR, methacrylate resin.
CS, calcium silicate; ER, epoxy resin; μCT, micro-computed tomography; CH, calcium hydroxide; MR, methacrylate resin.
CS, calcium silicate; ER, epoxy resin; CH, calcium hydroxide; MR, methacrylate resin.
MR, methacrylate resin; ER, epoxy resin; hTGSC, human tooth germ stem cell; CH, calcium hydroxide; hPDL, human periodontal ligament; CP, calcium phosphate; ZOE, zinc oxide-eugenol; CS, calcium silicate; HGF-1, human gingival fibroblast; hPDLSC, human periodontal ligament stem cell.
ER, epoxy resin; MR, methacrylate resin; CH, calcium hydroxide; ZOE, zinc oxide-eugenol; DCT, direct contact test; ADT, agar diffusion test; CLSM, confocal laser scanning microscopy; SEM, scanning electron microscopy; CS, calcium silicate.
ER, epoxy resin; COL, collagen; OCN, osteocalcin; BSP, bone sialoprotein; CH, calcium hydroxide; hTGSC, human tooth germ stem cell; DSPP, dentin sialophosphoprotein; CP, calcium phosphate; CS, calcium silicate; PDL, periodontal ligament; ALP, alkaline phosphatase; ON, osteonectin; OPN, osteopontin; Runx, runt-related transcription factor; ZOE, zinc oxide-eugenol; hPDL, human periodontal ligament; BMP, bone morphogenic protein; TGF, transforming growth factor; VEGF, vascular endothelial growth factor; DMP, dentin matrix protein; BSP, bone sialoprotein; CaP, calcium phosphate; Msx, msh homeobox.